SEC Filing Analysis: Revolution Medicines, Inc. (RVMD)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at Revolution Medicines has filed a notice to sell 10,000 shares valued at approximately $627,300, executed under a pre-established 10b5-1 trading plan.
• Market Impact: The transaction is too small to have a material impact on the stock, representing a negligible fraction of the company's market capitalization and public float.

Company Information

Field	Value
Company	Revolution Medicines, Inc.
Ticker Symbol	RVMD
CIK	0001628171
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Jack Lee Anders
CIK	0001800668
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-11
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	10,000
Price Per Share	$62.73
Total Value	$627,300
Shares Owned After	Not Disclosed
Ownership Type	Not Disclosed

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$627,300
% of Market Cap	0.0053%
Shares Transacted	10,000
% of Shares Outstanding	0.0053%
Post-Transaction Ownership	Not Disclosed
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with an $11.79 billion market capitalization, this $627k transaction is financially immaterial.
• Ownership Concentration: Ownership details post-transaction are not provided, but the sale size is too small to significantly alter the insider's core holding.
• Transaction Significance: The sale represents less than 0.01% of both the market cap and shares outstanding, placing it firmly in the 'Low' significance category. It is a routine liquidity event for the insider.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale was conducted under a 10b5-1 trading plan adopted on December 16, 2024. Such pre-scheduled plans are not based on current material non-public information and are typically disregarded by the market.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is minor compared to the stock's average daily trading volume.
• Sentiment Indicator: Neutral. This is a routine, planned disposition and does not signal any change in the insider's confidence in the company.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly states the sale is part of a 10b5-1 plan, which automates transactions at predetermined times. The filing also notes a pattern of recent sales by the same insider, reinforcing the routine nature of the activity.